The IFNγ-expressing CAR T cells may change the local tumor microenvironment such as M2-to-M1 macrophage differentiation or stimulate incoming tumor-infiltrating T cells and, thus gradually lead to tumor regression. This evidence concerns the gene IFNG and neoplasm.